norgestrel has been researched along with Venous Thrombosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lidegaard, O; Løkkegaard, E; Nielsen, LH; Skovlund, CW | 1 |
| Atreja, A; Falcone, T; Harris, CM; Jain, A; Thacker, HL | 1 |
| Szarewski, A | 1 |
| Cole, JA; Doherty, M; Norman, H; Walker, AM | 1 |
| Burkman, RT | 1 |
| Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
| Milsom, I; Odlind, V; Persson, I; Victor, A | 1 |
1 review(s) available for norgestrel and Venous Thrombosis
| Article | Year |
|---|---|
Hormonal contraception: recent advances.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethisterone; Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Norgestrel; Oximes; Venous Thrombosis; Women's Health | 2006 |
1 trial(s) available for norgestrel and Venous Thrombosis
| Article | Year |
|---|---|
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
6 other study(ies) available for norgestrel and Venous Thrombosis
| Article | Year |
|---|---|
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Topics: Adolescent; Adult; Anticoagulants; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Denmark; Drug Implants; Epidemiologic Methods; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Transdermal Patch; Venous Thrombosis; Young Adult | 2012 |
How should we advise patients about the contraceptive patch, given the FDA warning?
Topics: Contraceptives, Oral, Combined; Counseling; Drug Combinations; Drug Utilization; Ethisterone; Female; Humans; Norgestrel; Oximes; Physician-Patient Relations; Practice Patterns, Physicians'; Risk Assessment; United States; United States Food and Drug Administration; Venous Thrombosis | 2006 |
Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
Topics: Administration, Cutaneous; Brain Ischemia; Case-Control Studies; Cohort Studies; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Myocardial Infarction; Norgestrel; Stroke; Thromboembolism; Venous Thrombosis | 2007 |
Transdermal hormonal contraception: benefits and risks.
Topics: Adhesiveness; Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norgestrel; Patient Compliance; Patient Satisfaction; Venous Thrombosis | 2007 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis | 2002 |